Featured Research

from universities, journals, and other organizations

Nanotechnology against pollen allergy

Date:
February 11, 2013
Source:
Charité - Universitätsmedizin Berlin
Summary:
Scientists have now been able to identify the grass pollen molecule, against which the allergic response of hay fever in children is initiated. In addition, it was shown that the first individual antibodies generated in children against individual pollen molecules can be identified even before the initial symptoms of a pollen allergy are developed.

Scientists at the Charité -- Universitätsmedizin Berlin have now been able to identify the grass pollen molecule, against which the allergic response of hay fever in children is initiated. In addition, it was shown that the first individual antibodies generated in children against individual pollen molecules can be identified even before the initial symptoms of a pollen allergy are developed.

The findings of this long-term study have appeared in the Journal of Allergy and Clinical Immunology.

In its study, the Molecular Allergology working group headed by Adj. Professor Dr. Paolo Matricardi of the Department of Pediatrics, Division of Pneumonology and Immunology at the Campus Virchow-Klinikum, investigated the data and blood samples taken from 820 children. These children come from five cities in Germany and had been taking part in this multicenter allergy study since their birth in 1990. As part of a sub-project investigating the development of the allergic immune response in childhood, which was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation), the working group was for the first time also able to examine the data using nanotechnological methods at a molecular level. Hitherto in current allergy diagnostics, antibodies against a natural grass pollen extract (a mixture of several allergenic modules) are detected.,. In this study, a so-called allergen chip was used, which enables antibodies against individual, microscopically small pollen molecules to be made visible and identified.

The research findings of the study show that the special proteins used by the body's immune system to repel invading pathogens, the so-called IgE antibodies, can be developed years before the first symptoms occur. These antibodies can be identified in children even at pre-school age. They represent key biomarkers that indicate whether a child will suffer from a grass pollen allergy. In addition, a single pollen molecule was identified, the so-called Phl p 1, which in most cases stands at the head of the reaction chain: although the children affected initially only develop a few IgE antibodies to a specific type of pollen, they subsequently create other IgE antibodies to other pollen molecules as well. The immune system responds to an increasing number of different allergens, often before allergic symptoms are recognisable. Methods of treatment, such as hypo- or desensitisation, do not invariably lead to success. One reason for this might be that the therapy does not start until the children affected are already suffering from the allergy, and the body has already created antibodies against a range of different allergen molecules.

"The detection of lgE antibodies at an early stage could enhance the prospects of a successful therapeutic and even preventative intervention," according to a confident Laura Hatzler, the first author of the study. "The investigation of allergen-specific, immunological treatments at early stages of the disease process in childhood represents the next step in our research."


Story Source:

The above story is based on materials provided by Charité - Universitätsmedizin Berlin. Note: Materials may be edited for content and length.


Journal Reference:

  1. Laura Hatzler, Valentina Panetta, Susanne Lau, Petra Wagner, Renate L. Bergmann, Sabina Illi, Karl E. Bergmann, Thomas Keil, Stephanie Hofmaier, Alexander Rohrbach, Carl Peter Bauer, Ute Hoffman, Johannes Forster, Fred Zepp, Antje Schuster, Ulrich Wahn, Paolo Maria Matricardi. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. Journal of Allergy and Clinical Immunology, 2012; 130 (4): 894 DOI: 10.1016/j.jaci.2012.05.053

Cite This Page:

Charité - Universitätsmedizin Berlin. "Nanotechnology against pollen allergy." ScienceDaily. ScienceDaily, 11 February 2013. <www.sciencedaily.com/releases/2013/02/130211090842.htm>.
Charité - Universitätsmedizin Berlin. (2013, February 11). Nanotechnology against pollen allergy. ScienceDaily. Retrieved August 29, 2014 from www.sciencedaily.com/releases/2013/02/130211090842.htm
Charité - Universitätsmedizin Berlin. "Nanotechnology against pollen allergy." ScienceDaily. www.sciencedaily.com/releases/2013/02/130211090842.htm (accessed August 29, 2014).

Share This




More Health & Medicine News

Friday, August 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) — Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com
Killer Amoeba Found in Louisiana Water System

Killer Amoeba Found in Louisiana Water System

AP (Aug. 28, 2014) — State health officials say testing has confirmed the presence of a killer amoeba in a water system serving three St. John the Baptist Parish towns. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Who Could Be Burnt by WHO's E-Cigs Move?

Who Could Be Burnt by WHO's E-Cigs Move?

Reuters - Business Video Online (Aug. 28, 2014) — The World Health Organisation has called for the regulation of electronic cigarettes as both tobacco and medical products. Ciara Lee looks at the impact of the move on the tobacco industry. Video provided by Reuters
Powered by NewsLook.com
CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

Newsy (Aug. 28, 2014) — CDC director Tom Frieden says the Ebola outbreak is even worse than he feared. But he also said there's still hope to contain it. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins